Tekla Healthcare Investors (HQH) Comparison with companies in other sectors?

Tekla Healthcare Investors has a share price of 53.86M. You can analyze Tekla Healthcare Investors (HQH) competitors across different market sectors through stock heatmaps.

What are HQH's NET and operating margins?

Tekla Healthcare Investors (HQH) operating margin is around -0.02, and net profit margin is approximately 17.17 as of the latest reports.

In what way does HQH's earnings per share (EPS) trend reflect its financial momentum?

Tekla Healthcare Investors (HQH) EPS is 0.13 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Tekla Healthcare Investors is 126.54, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Tekla Healthcare Investors?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Tekla Healthcare Investors like P/E which is 4.75, P/B which is 0.83, and PEG which is 0.03. Compare them with sector averages to evaluate if the stock is priced fairly.

Tekla Healthcare Investors

HQH•NYSE

Financial Services

Asset Management

$16.26

$0.00(0.00%)

Tekla Healthcare Investors (HQH) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.13

P/E Ratio

126.54

ROE

0.18%

Net Margin

17.17%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$886.03M

Shares OutstandingTotal number of shares issued

$53.86M

Book Value/ShareNet worth per share

$19.76

Revenue/ShareAnnual revenue per share

$0.20

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.13

Net MarginNet income as percentage of revenue

1717.36%

Operating MarginOperating income as percentage of revenue

-2.05%

ROEReturn on shareholders' equity

17.89%

ROAReturn on total assets

17.43%

ROCEReturn on capital employed

-0.02%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$0.00

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$2.32

Dividend YieldAnnual dividend as percentage of stock price

14.14%

Financial Ratios Analysis data is not available for HQHFinancial Ratios Analysis details for HQH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for HQHSector Benchmarking details for HQH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Tekla Healthcare Investors Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Tekla Healthcare Investors. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Tekla Healthcare Investors's unique business strengths and challenges.

Key Financial Metrics for Tekla Healthcare Investors

For Tekla Healthcare Investors, essential financial indicators include EPS 0.13, PE 126.54, and ROE 0.18. These key ratios reveal insights into Tekla Healthcare Investors's profitability, valuation, and operational health. Understanding these metrics enables you to compare Tekla Healthcare Investors with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Tekla Healthcare Investors

Metrics like Net Margin 1717.36% and ROA 17.43% shed light on how well Tekla Healthcare Investors is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Tekla Healthcare Investors can sustain its operations and continue growing in the future.

Valuation and Market Position of Tekla Healthcare Investors

Using ratios such as P/B Ratio 0.83 and PEG Ratio 0.03, investors can assess whether Tekla Healthcare Investors is appropriately valued based on its financials and growth potential. These figures, combined with Tekla Healthcare Investors's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Tekla Healthcare Investors

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Tekla Healthcare Investors's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Tekla Healthcare Investors, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Tekla Healthcare Investors

Investing in Tekla Healthcare Investors based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Tekla Healthcare Investors focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;